Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-13

Clinical Trial Update: Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating transplantation of human umbilical cord-derived mesenchymal stem cells with an injectable collagen scaffold for premature …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUC-MSCs with Injectable Collagen Scaffold (human umbilical cord-derived mesenchymal stem cells with injectable collagen scaffold)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Premature Ovarian Failure | Phase 1, Phase 2 | Status: COMPLETED